2004
DOI: 10.1016/j.jhep.2004.01.010
|View full text |Cite
|
Sign up to set email alerts
|

Establishment of an orthotopic tumour model for hepatocellular carcinoma and non-invasive in vivo tumour imaging by high resolution ultrasound in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
34
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 30 publications
(37 citation statements)
references
References 15 publications
3
34
0
Order By: Relevance
“…An orthotopic syngenic tumor model was used as described. 22 Briefly, 5 ϫ 10 4 Hepa129 cells were injected into the liver lobe of C3H mice. Treatment was initiated on day 4 after tumor cell implantation, with mice receiving: (1) 17-DMAG 25 mg/ kg, 3ϫ/wk, (2) rapamycin 0.2 mg/kg/day, (3) combination therapy, or (4) diluent.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…An orthotopic syngenic tumor model was used as described. 22 Briefly, 5 ϫ 10 4 Hepa129 cells were injected into the liver lobe of C3H mice. Treatment was initiated on day 4 after tumor cell implantation, with mice receiving: (1) 17-DMAG 25 mg/ kg, 3ϫ/wk, (2) rapamycin 0.2 mg/kg/day, (3) combination therapy, or (4) diluent.…”
Section: Methodsmentioning
confidence: 99%
“…Therefore, we validated our results in a C3H syngenic orthotopic tumor model using Hepa129 cells. 22 Because this tumor model elicits an aggressive growth behavior, we stepped up the treatment schedule by administering 17-DMAG three times per week (25 mg/kg) and rapamycin at 0.2 mg/kg/day. Single therapy with either 17-DMAG or rapamycin had no effect on hepatic tumor incidence (Fig.…”
Section: Effects Of Hsp90 and Mtor Inhibition On Hepaticmentioning
confidence: 99%
“…All experimental procedures were carried out according to the regulations and internal biosafety and bioethics guidelines of Harbin Medical University. Experimental orthotopic HCC was induced as described previously [18]. Briefly, the mice were randomly divided into three groups (n = 10 in each group) to receive subcapsular injection of 2 9 10 6 mock, SC-1 or SC-2 cells per mouse into the left liver lobe.…”
Section: Orthotopic Hcc Modelmentioning
confidence: 99%
“…Usually, experimental antitumor strategies are tested in subcutaneous, but rarely in orthotopic, hepatoma models (29,30). Previously, the Hepa129 hepatoma cell line has been demonstrated to be suitable for orthotopic tumor growth and also for therapeutic intervention studies (29,31). Furthermore, our previous data demonstrated that liver fibrosis had a strong impact on orthotopic HCC growth.…”
Section: Discussionmentioning
confidence: 99%